STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [144] CoreWeave, Inc. SEC Filing

CoreWeave (NASDAQ: CRWV) insider eyes new 200K-share sale after 10b5-1 trades

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) insider Michael Intrator filed a Rule 144 notice to sell 200,000 shares of CoreWeave common stock through Morgan Stanley Smith Barney, with a proposed aggregate sale price of $21,200,000 based on NASDAQ trading on 08/18/2026. The notice references 458,871,690 common shares outstanding. The 200,000 shares to be sold were acquired upon the vesting of Preferred Stock Conversion awards during the period from 02/25/2019 through 04/14/2023. The filing also lists numerous prior 10b5-1 plan sales over the past three months by Intrator and Omnadora Capital LLC.

Positive

  • None.

Negative

  • None.
Shares to be sold under Rule 144 200,000 shares Common stock proposed for sale by Michael Intrator as of 08/18/2026
Proposed aggregate sale price $21,200,000.00 Aggregate price for 200,000 common shares referenced in Rule 144 notice
Common shares outstanding 458,871,690 shares Common stock outstanding figure associated with the Rule 144 securities information
10b5-1 sale by Intrator on 06/16/2026 200,000 shares; $23,330,520.00 Common stock sold under 10b5-1 plan on 06/16/2026 by Michael Intrator
10b5-1 sale by Omnadora on 06/16/2026 107,692 shares; $12,562,551.80 Common stock sold under 10b5-1 plan on 06/16/2026 by Omnadora Capital LLC
10b5-1 sale by Intrator on 05/19/2026 200,000 shares; $19,666,200.00 Common stock sold under 10b5-1 plan on 05/19/2026 by Michael Intrator
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
10b5-1 regulatory
"10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave."
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Preferred Stock Conversion financial
"Preferred Stock Conversion during the period of 02/25/2019 through 04/14/2023."
Form 144 regulatory
"144: Securities To Be Sold Common | 02/25/2019 | Preferred Stock Conversion"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

What did CoreWeave (CRWV) insider Michael Intrator file in this Form 144?
Michael Intrator filed a Rule 144 notice indicating an intention to sell 200,000 CoreWeave common shares through Morgan Stanley Smith Barney, with a proposed aggregate sale price of $21,200,000 based on NASDAQ prices as of 08/18/2026.

How many CoreWeave (CRWV) shares are referenced as outstanding in this Form 144?
The notice references 458,871,690 common shares outstanding for CoreWeave. This figure appears in the securities information section tied to the common stock being reported in connection with the Rule 144 planned sale.

What is the origin of the 200,000 CoreWeave (CRWV) shares to be sold under Rule 144?
The 200,000 shares were acquired upon vesting of Preferred Stock Conversion awards during the period from 02/25/2019 through 04/14/2023, as stated in the remarks section accompanying the Rule 144 notice.

Does the CoreWeave (CRWV) Form 144 describe prior 10b5-1 sales by Michael Intrator?
Yes. The filing lists multiple 10b5-1 sales by Michael Intrator over the past three months, including several 200,000-share transactions such as one on 06/16/2026 with total proceeds of $23,330,520.00.

Who else, besides Michael Intrator, is shown selling CoreWeave (CRWV) shares under 10b5-1 plans?
The document also lists Omnadora Capital LLC as a seller in multiple 10b5-1 plan transactions. For example, Omnadora sold 107,692 shares of CoreWeave common stock on 06/16/2026 for total proceeds of $12,562,551.80.

What brokerage firm is handling the proposed CoreWeave (CRWV) Rule 144 sale?
The proposed Rule 144 sale of 200,000 CoreWeave common shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR